Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1994-06-16
1995-12-12
Warden, Jill
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 3, 530304, A61K 3828, C07K 1462
Patent
active
054749786
ABSTRACT:
The present invention discloses a human insulin analog hexamer complex and formulations. More specifically, the present invention relates to various parenteral formulations, which comprise: human insulin analogs in a hexamer conformation, zinc ions, and at least three molecules of a phenolic derivative selected from the group consisting of m-cresol, phenol, or a mixture of m-cresol and phenol. The formulation provides a rapid onset of action.
REFERENCES:
patent: 3060093 (1962-10-01), Poulsen et al.
patent: 4608634 (1986-06-01), Grau
patent: 5028587 (1991-07-01), Dorschug et al.
patent: 5149777 (1992-09-01), Hansen et al.
patent: 5164366 (1992-11-01), Balschmidt et al.
Ser. No. 08/057201, Chance, et al. May 5, 1993.
Howey, et al., Diabetes, 43, 396-402 (Mar. 1994).
Diabetes, 41, Suppl. 1, 192A (1992).
Brems, et al., Protein Engineering, 5:6, 519-525 (1992).
Heinemann, et al., Diabetologia, 33, 384-386 (1990).
Kirk-Othmer, Encyclopedia of Chemical Technology 13, 607-614 (1981).
Bruce H. Frank, Text and Slide copies of lecture given at the Conference on Insulin, Self Association and Conformational Studies on Human Proinsulin and Insulin Analogs, University of York, Aug. 29-Sep. 1, 1989.
Wollmer et al., Phenol-Promoted Structural Transformation of Insulin in Solution from the 2nd Assisi International Symposium on Advanced Models for the Therapy of Insulin-Dependent Diabetes, 903-911 (Apr. 1986).
Diabetologia, 30, 503A, (1987).
Brange, et al., Nature, 333:16, 679-682 (Jun. 1988).
Brange, et al., Diabetes Care, 13:9, 923-954 (Sep. 1990).
Dodson, et al., Phil Trans. R. Soc. Lond. A 345, 153-164 (1993).
Brange, Galenics of Insulin: The Physico-chemical and Pharmaceutical Aspects of Insulin and Insulin Preparations, Springer-Verlag Berlin Heidelberg, Germany (1987) pp. 1-103.
Wollmer, et al., Biol. Chem. Hoppe-Seyler, 370, 1045-1053 (Sep. 1989).
Brems, et al., Protein Engineering, 5:6, 527-533 (1992).
Derewenda, et al., Nature, 338:13, 594-596 (Apr. 1989).
Brader, et al., Biochemistry, 30, 6636-6645 (1991).
Harding, et al., The Crystal Structure of Insulin: II. An Investigation of Rhombohedral Zinc Insulin Crystals and a Report of Other Crystalline Forms Chemical Crystallography Laboratory, South Parks Road, Oxford, England, 212-226 (8 Nov. 1965).
Brange, et al., Structural Biology, 1, 934-940 (1991).
Bakaysa Diane L.
Brems David N.
Frank Bruce H.
Havel Henry A.
Pekar Allen H.
Boone David E.
Caltrider Steven P.
Dahling Gerald V.
Eli Lilly and Company
Prickril Benet
LandOfFree
Insulin analog formulations does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Insulin analog formulations, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Insulin analog formulations will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1359774